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Abstract
Purpose The aim of this study was to evaluate the diag-
nostic accuracy of postnatal multidetector computed
tomography (MDCT) compared with prenatal ultrasound
(US), surgical findings, and histology, in 33 patients with
congenital cystic lung disease.
Methods Thirty-three patients, 17 males and 16 females,
were evaluated by MDCT. Twenty-seven of these patients
underwent prenatal US between week 18 and 22, and
between week 32 and 35 of gestation. Lung lobectomy,
segmentectomy, atypical resection, lesion resection were
performed in 31 patients and surgical specimens were
analysed.
Results Prenatal US and MDCT correctly diagnosed 76.9
and 94 % of the lesions, respectively. Disagreement
occurred in six lesions with prenatal US and in two lesions
with MDCT. No statistically significant differences were
observed between the two techniques (P = 0.122).
Conclusions As most surgeons consider the surgical
resection of these lesions mandatory, our study underscores
the essential role of imaging, in particular CT, in providing
invaluable preoperative information on congenital cystic
lung diseases recognised in uterus.
Keywords Multidetector computed tomography 
Congenital cystic lung disease  Congenital lung
malformation  Prenatal ultrasound
Introduction
The first bud of the respiratory tract appears around the
fourth week of gestation and originates from the ventral
anterior primitive intestine (respiratory diverticulum).
Errors at this stage of development are responsible for
congenital lung malformations that can be divided into two
groups: (a) dysmorphic lung, namely lung agenesis, aplasia
and hypoplasia, (b) ‘‘focal’’ malformations or congenital
cystic lung diseases (CCLD), namely congenital pulmon-
ary airway malformation (CPAM), pulmonary sequestra-
tion (PS), congenital lobar emphysema (CLE), and
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bronchogenic cyst (BC). These last malformations are the
focus of our study [1].
CPAMs make up almost 30–40 % of all congenital lung
lesions, and are characterised by an excessive overgrowth of
the terminal respiratory bronchioles and lung structures with
alveolar growth suppression [2]. Genes such as HOXB5, Fgf7,
and platelet-derived growth factor-B (PDGF-B) have been
implicated in the pathogenesis of CPAM [3–5]. The first
Stocker classification from 1977 [6] has been modified and
now includes lesions from type 0 to type IV based on the origin
of the malformation [7]. Among these lesions, type I are the
most frequent while type III lesions are characterised by worse
prognosis. Associated malformations involving other organs
may be present. PS is the second most common lesion after
CPAM, characterised by a portion of lung parenchyma that
does not connect with the tracheobronchial system and is
therefore not ventilated whereas a systemic arterial supply is
always present [2]. Based on the age of onset, PS may be
distinguished in intralobar and extralobar; the latter may be
associated with other congenital anomalies [1, 8, 9]. CLE is a
structural disorder linked to anomalous cartilage development
of the bronchus, resulting in the overinflation of one or more
pulmonary lobes. Finally, BC occurs at a very early age and
originates from an abnormal budding tracheobronchial tree,
followed by its non-branching process [1, 8].
The first imaging approach to detect CCLD disease is
prenatal ultrasound (PUS), which is usually performed at
18–22 weeks of gestation and allows screening and defi-
nition of foetal lung lesions in the majority of cases [10].
Foetal magnetic resonance imaging is also a valuable tool
for prenatal diagnosis of CCLD, but for the time being it is
only available in few centres.
After birth, multidetector computed tomography (MDCT)
plays a key role in the radiological diagnosis of CCLD in
children, confirming type and number of lesions and their
characterisation, and allowing a thorough preoperative eval-
uation [8]. MDCT offers the highest spatial resolution and
enhanced diagnostic quality, together with multiplanar refor-
mation, which is very informative for the surgeon [11].
Our study aimed to retrospectively evaluate the diag-
nostic accuracy of MDCT in 33 patients with CCLD. We
also compared MDCT with PUS and with surgical and
histological findings (and with histology) to evaluate the
diagnostic performance of MDCT in defining the right
diagnosis and the best surgical planning.
Materials and methods
Patient population
Our institutional review board approved the review of
radiological, surgical, and pathological data for this
retrospective study. The requirement for parent informed
consent was waived. Imaging evaluation included prenatal
US and postnatal MDCT.
From June 2004 to April 2012, 33 children with CCLD
were evaluated at the Children’s Hospital in Brescia, Italy.
Our population included 17 males (51.5 %) and 16 females
(48.5 %). Age distributions at diagnostic examination and
at surgery are presented as box and whisker plots in Fig. 1.
According to Tukey’s notation [Tukey, John (1977),
Exploratory Data Analysis, Addison–Wesley], reported
minimum and maximum values are filtered excluding all
the outlier points, i.e. points that are greater than 1.5 times
the interquartile range. Median, minimum and maximum
age at PUS were 20, 19 and 22 weeks, respectively, with 5
outlier values; at CT evaluation, they were 9, 0 and
26 weeks, respectively, with 2 outliers; at surgery they
were 17, 0 and 43 weeks, respectively, with 2 outliers.
Seventeen patients (51.5 %) were asymptomatic at birth,
the others showed symptoms related to respiratory distress.
Prenatal US
In accordance with the international literature [10, 12], the
scheduled morphological routine US examination between
week 18 and 22 of gestation and PUS evaluation at the
third trimester and between week 32 and 35 of gestation
were available for the analysis in 27/33 (81.8 %) patients.
In some patients, additional US investigations were per-
formed also in late pregnancy to rule out cardiovascular
failure, foetal hydrops or polyhydramnios.
PUS was performed by two expert obstetrician–gynae-
cologists (N.P., M.S.) with an Acuson US scanner (Sie-
mens Medical Systems, Erlangen, Germany) and a
3.5 MHz convex probe. PUS findings were defined
according to the following patterns: (1) homogeneous
Fig. 1 Patients’ age distribution at prenatal ultrasound (PUS), at
postnatal multidetector computed tomography (MDCT) and at
surgery
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hyperechoic lesion (CPAM III); (2) mixed lesion with
echogenic component and anechoic component [macrocy-
stic [2 cm (CPAM I) or microcystic \2 cm (CPAM II)];
(3) hyperechoic mass with anomalous arterial supply aris-
ing from the aorta (PS); (4) isolated, regular hypoechoic
area in the lung (BC).
MDCT
Chest examinations were performed with a 6-slice MDCT
scanner (Emotion 6, Siemens Medical Systems, Erlangen,
Germany). The area of coverage extended from the tho-
racic inlet to the diaphragmatic level or just above the renal
arteries in the case of a subdiaphragmatic mass detected at
PUS. MDCT parameters included 6-mm collimation with
age- and weight-based tube current and voltage, high-speed
mode, and pitch ranging from 1.0 to 1.5. In all cases, dose
modulation was used to minimise the radiation dose.
MDCT was performed after intravenous injection of
2 mL/kg of non-ionic contrast medium (320 mg I/mL).
Contrast medium was injected into an antecubital vein with
a power injector at a rate of 1.0 mL/s for a 24-gauge
catheter, and 1.5–2.0 mL/s for a 22-gauge catheter. Mul-
tiplanar (MPR) and 3D reconstructions were acquired for
each examination. All patients were sedated.
All examinations were randomly reviewed by two pae-
diatric radiologists (M.P.B., G.D.G.), who were blinded to
the prenatal US findings and clinical information. When the
reviewers expressed discordant opinions, they reached a
consensus by means of a joint review of the recorded
images with an additional radiologist (R.M.).
The analysis of the MDCT scans considered the fol-
lowing patterns: (1) homogeneously solid lesion (CPAM
III); (2) mixed solid lesion with large cysts[2 cm (CPAM
I) or small cysts \2 cm (CPAM II); (3) cystic or solid
lesions associated with anomalous systemic arterial supply
and venous drainage in intralobar or extralobar PS; (4)
hyperinflated lobe with attenuated and displaced vascular
structures (CLE); (5) well-circumscribed round or ovoid
solitary lesion with uniform fluid attenuation (BC).
Lesion location was assessed according to the standard
nomenclature: right upper, middle, lower lobe; left upper,
lingula and lower lobe.
Surgery
The thorax was entered through a posterolateral incision,
with a muscle sparing technique. Lung lobectomy, seg-
mentectomy, atypical resection or lesion resection were
performed when appropriate. All the surgical specimens
were sent for histological examination.
Histology
Surgical specimens were sent to the Surgical Pathology
Laboratory in buffered formalin 4 % fixative solution.
Gross examination was done after fixation. Samples of the
specimens were taken for histology, particularly including
cysts, nodules and apparently normal lung when recogni-
sed, or random when no gross differences were evident.
After sample processing and paraffin embedding, slides for
microscopy examination were stained with haematoxylin–
eosin. Histochemical or immunohistochemical stains were
performed when considered appropriate. Histologically
specific features related to pulmonary malformations were
evaluated: architecture of lung parenchyma, radial alveolar
count, cysts, abnormal vessels, lining of cysts, presence of
cartilage, goblet cells, muscle cells, sarcomatous compo-
nent, inflammatory tissue.
Statistical analysis
Summary statistics was performed by means of the Tukey’s
box–whisker plot, and was carried out with Statgraphic
Centurion XV software (StatPoint Technologies, http://
www.statgraphic.com). For the comparison of MDCT and
PUS frequency of the overall correct and incorrect diag-
nosis (CPAM, PS and BC), a parametric exact Fisher test
was performed using the utilities from the Stanton A. Glanz
CD-Rom [13]. The sensitivity and specificity of the two
diagnostic approaches in differentiating the pathologies
were compared with a Chi-squared test. As histology was
considered the gold standard for diagnosis, MDCT and
PUS findings were compared with histology. For all tests,
the confidence level was set at 0.05.
Results
Prenatal US
Twenty-eight lesions were detected in 27 out of 33 patients
for whom PUS was available for the study.
As shown in Table 1, CPAM was diagnosed in 18
patients (66.6 %): four had CPAM type I (22.2 %), 11
CPAM type II (61.1 %), and three CPAM type III
(16.6 %). One patient with PS had also CPAM type II in
the same affected lung lobe. This CPAM lesion was
included in the CPAM statistical analysis for a total of 19
lesions. Lesions showed size changes at the ultrasound
follow-up in 10/18 subjects (55.5 %): in particular, in 4/10
cases (40 %) (three CPAM type II and one CPAM type I)
the lesions were no longer detectable at the last assessment
at 32 weeks of gestation, in 3/10 cases (30 %) (CPAM type
844 Radiol med (2014) 119:842–851
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III) the lesions had increased in size and in 3/10 cases
(30 %) (CPAM type III) they had decreased in size.
Eight patients (29.6 %) were diagnosed with PS. In 7/8
patients (87.5 %), the diagnosis was easily established; in
one case (12.5 %), despite highly suggestive imaging for
PS, the diagnosis was only suspected due to the failure to
detect an afferent systemic artery.
One patient (3.7 %) was diagnosed with BC.
MDCT
MDCT was performed in all 33 patients (27 with a prenatal
diagnosis and 6 symptomatic patients with no prenatal
diagnosis). The data are summarised in Table 2.
CPAM was detected in 15 patients (45.4 %). In partic-
ular, five had CPAM type I (33.3 %), nine CPAM type II
(60 %), and one CPAM type III (6.6 %). Two patients with
intralobar PS had also CPAM type I and II, respectively,
for a total of 17 lesions.
Lesions were detected in the right lung in ten patients
(four CPAMs were located in the right upper lobe, two in
the middle lobe, and four in the right lower lobe), and in
the left lung in eight patients (two CPAMs were located in
the upper lobe, one in the lingula, and five in the lower
lobe).
PS was detected in 14 patients (42.4 %): PS was intra-
lobar in 4 patients and extralobar in 10. In two patients, the
lesion was found under the left side of the diaphragm.
Lesions were located in the left lower thoracic cavity in
50 % of cases (7/14) and in the right lower thoracic cavity
in 35.7 % of the cases (5/14); in 14.2 % of the cases (2/14),
the lesions were next to the left adrenal gland.
In three patients (9.1 %), the diagnosis was consistent
with CLE in the left upper and lower lobe and in the right
lower lobe, respectively.
In one patient (3.0 %), the diagnosis was consistent with
right BC in the right lower lobe. Lesion location is shown
in Table 3.
Surgery
Thirty-one patients underwent surgery. Mean patient age at
surgery was 156 days (range, 3 days–24 months). Con-
cerning CPAM, lung lobectomy was performed in five
patients, lung segmentectomy was performed in five
patients, and atypical resection in three patients. The ten
patients with extralobar PS underwent lesion resection, the
four patients with intralobar PS underwent atypical pul-
monary resection including the sequestration in two cases,
and lobectomy in two patients. Patients with CLE under-
went lobectomy, and the only patient with BC underwent
evacuation by puncture and cystic resection.
No postoperative complications were observed.
Table 1 US findings during prenatal screening in 27/33 patients
CPAM type I 4
CPAM type IIa 11
CPAM type III 3
PSa 8
BC 1
CPAM congenital pulmonary airway malformation, PS pulmonary
sequestration, BC bronchogenic cyst
a One patient with PS and CPAM type II (hybrid lesion)
Table 2 CT findings in 33 patients
CPAM type Ia 5
CPAM type IIa 9
CPAM type III 1
Extralobar PS 10
Intralobar PS* 4
CLE 3
BC 1
CLE congenital lobar emphysema
a Two patients with intralobar PS had CPAM type I and II (hybrid
lesions)
Table 3 Location of lesions on MDCT in 33 patients
CPAM
(15 pt)
PS (14 pt) CLE
(3 pt)
BC (1 pt)
Left lobe
Left upper lobe 2/15
(13.3 %)
1/3
(33 %)
Lingula 1/15
(6.6 %)
Left lower lobe 5/15
(33.3 %)
7/14
(50 %)
1/3
(33 %)
Right lobe
Right upper lobe 4/15
(26.6 %)
Middle lobe 2/15
(13.3 %)
Right lower lobe 4/15
(26.6 %)
5/14
(35.7 %)
1/3
(33 %)
1/1
(100 %)
Abdomen
(adrenal gland)
2/14
(14.2 %)
Table 4 Comparison of prenatal US and MDCT findings
US MDCT
Lesions detected 20/26 (76.9 %) 31/33 (94 %) P = 0.122
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Fig. 2 Patient with congenital pulmonary airway malformation
(CPAM) type II. On PUS at 20 weeks of gestation (a) a large,
hyperechoic lesion (arrowheads) with small hypoechoic cystic areas
(clippers) can be detected. Unenhanced MDCT scans in axial (b,
c) and coronal planes (d) show, in the left lower lobe, multiple small
thin-wall cysts (arrows). On microscopic view (e), dilated alveolar
spaces lined by normal bronchiolar epithelium can be appreciated
(H&E, 910)
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Histology
Histology still remains the gold standard for the diagnostic
confirmation of CCLD.
Histological examination of the 33 lesions showed:
• CPAM in 15 cases (45.5 %): five CPAM type I
(33.3 %), nine CPAM type II (60 %) (two of them
associated with PS–hybrid lesions), and one CPAM
type III (6.6 %).
• PS in 14 cases (42.4 %).
• CLE in two cases (6 %).
• BC in one case and inflammatory tissue in one case
(3 %).
Comparison between PUS and histological findings
Out of the 27 patients evaluated with PUS, 25 underwent
surgery for a total of 26 lesions. PUS was suggestive of the
correct diagnosis in 20 out of 26 lesions (76.9 %), 11
CPAM, eight PS, and one BC, as confirmed by histology.
Of the two cases of CPAM associated with PS, US cor-
rectly identified the two different lesions in only one case,
while the other case was diagnosed as PS only. Disagree-
ment occurred in 6 out of 26 lesions (23 %). In particular,
one case of CPAM type II was shown to be inflammatory
tissue. Four lesions considered to be a CPAM type III were
actually PS; one case of CPAM type I was CLE. For
CPAM detection, PUS sensitivity and specificity were
respectively 100 and 60 %, whilst they were 66.7 and
100 % respectively for PS.
Comparison between MDCT and histological findings
Out of the 33 MDCT patients, 31 underwent surgery for a
total of 33 lesions. The comparison between MDCT
findings and histology showed a concordance in 94 % of
detected lesions (31/33), i.e. 14 CPAM, 14 PS, two CLE,
and one BC. Disagreement occurred in 2 out of 33 lesions
(6 %): one case of CPAM type II was shown to be
inflammatory tissue (possibly due to infection in CPAM).
One case diagnosed as CLE was actually CPAM type I.
MDCT sensitivity and specificity for CPAM detection were
93.3 % and 93.7 %, while they were both 100 % for PS.
Comparison between PUS findings and MDCT
PUS and MDCT diagnosed correctly 76.9 and 94 % of
lesions, respectively. No statistically significant differences
were observed between the two techniques (PUS and
MDCT), as shown in Table 4 (Fisher exact test,
P = 0.122).
More in detail, we considered each disorder separately:
• In CPAM, PUS raised the suspicion in 18 patients with
19 lesions, with histological confirmation in 11 out of
17 cases (positive predictive value, PPV = 64.7 %).
MDCT raised the suspicion in 15 patients with CPAM
and in 2 patients with combined PS and CPAM with a
total of 17 lesions with histological confirmation in
14/15 (PPV = 93.3 %). Comparison between the PUS
and MDCT findings was not significant for PPV and
sensitivity, while it was significant for specificity
(Fig. 2a–e).
• In PS, PUS was suggestive in eight patients with eight
lesions, and all were confirmed by histology
(PPV = 100 %). MDCT was suggestive in 14 patients
with 14 lesions, all of which were also confirmed by
histology (PPV = 100 %). MDCT sensitivity was sig-
nificantly different from PUS, while specificity and PPV
were the same for both diagnostic examinations and
always equal to 100 % (Table 5) (Figs. 3a–f, 4a–h).
Table 5 Comparison of
positive predictive value (PPV),
sensitivity and specificity for
US, CT and histological
findings
TN true negative, FP false
positive, FN false negative, FP
false positive
US vs. histology MDCT vs. histology
PPV CPAM 11/17 14/15 P = 0.596
64.7 % 93.3 %
PPV PS 8/8 14/14 Not applicable
100 % 100 %
Specificity CPAM 9/6 (TN/FP) 17/1 (TN/FP) 0.030
60.00 % (TN/(TN ? FP)) 94.44 % (TN/(TN ? FP))
Specificity PS 14/0 (TN/FP) 19/0 (TN/FP) Not applicable
100 % (TN/(TN ? FP)) 100 % (TN/(TN ? FP))
Sensitivity CPAM 11/0 (TP/FN) 14/1 (TP/FN) P = 1
100 % (TP/(TP ? FN)) 93.3 % (TP/(TP ? FN))
Sensitivity PS 8/4 (TP/FN) 14/0 (TP/FN) P = 0.033
66.66 % (TP/(TP ? FN)) 100 % (TP/(TP ? FN))
Radiol med (2014) 119:842–851 847
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• In the only observed case of BC, both PUS and MDCT
diagnoses were confirmed by histology;
• In CLE, only two out of three cases in which MDCT raised
a suspicion were histologically confirmed (PPV = 66 %),
the remaining case being a CPAM type I. As expected, no
diagnosis of CLE was established with PUS.
In 28 out of 31 patients (90.3 %), MDCT was in agree-
ment with surgical findings. In particular, MDCT overesti-
mated the extent of the lesions in three patients with CPAM.
Discussion
Congenital cystic lung diseases include a heterogeneous
group of anomalies affecting bronchi, lung parenchyma,
arterial supply, and venous drainage. The spectrum of these
abnormalities includes CPAM, PS, CLE, and BC [1].
The first diagnostic examination is PUS, usually per-
formed at 18–22 weeks of gestation, during the first
scheduled morphological evaluation of the foetus [14]. In
Fig. 3 Patient with intralobar pulmonary sequestration. PUS at
20 weeks of gestation (a) shows a homogeneously hyperechoic mass
(clippers). Postcontrast MDCT scans (b, c) reveal a hyperdense lesion
in the left lower lung (arrowhead) with a large artery originating from
the aorta (black arrow). Maximum intensity projection (MIP)
reconstruction (d) shows the systemic arterial supply (white arrow)
and the pulmonary venous drainage (white arrowhead). Low power
view of intralobar sequestration (e) shows pleural fibrosis and mild
inflammatory changes in pulmonary parenchyma with mucus in some
alveoli (H&E, 940)
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the literature, the diagnostic accuracy of this method ranges
between 56 and 77 %, very similar to our results [10, 15–
17].
It has been shown that during pregnancy these lesions
may display a variable pattern of growth: they can increase
or decrease in size, or even disappear [18]. In our series,
lesions increased in size in 30 % of cases, decreased in size
in 30 % of cases, and were no longer detectable at the last
PUS in 40 % of cases.
After birth, chest X-ray is no longer the first imaging
approach, as it fails to detect lesions in about 60 % of
asymptomatic patients [19]. However, in clinical practice,
chest X-ray is still used as the first-line approach only for
patients with respiratory distress. MDCT was performed in
all patients with a prenatal diagnosis of CCLD, regardless
to its evolution during pregnancy. Our MDCT examina-
tions were performed with age- and weight-based protocol
in accordance with the literature, achieving a reduced
biological aggressiveness in paediatric patients, particu-
larly in newborn babies and little infants, as were many
patients in this study [20–23]. Comparison among PUS and
MDCT findings showed a discrepancy with regards to
CCLD diagnosis. Specifically, PUS failed to properly
diagnose 23 % of cases and MDCT failed in only 6 % of
the analysed statistics, as later confirmed by histological
examination. However, statistical comparison did not
highlight any significant difference between the overall
results of the two techniques (P = 0.122). This finding
underscores the important role of MDCT in the evaluation
of CCLD. Furthermore, out of the four patients with no
longer detectable lesion at the last PUS, MDCT showed the
presence of CPAM in three cases and of PS in one case.
The accuracy of PUS and MDCT diagnosis was then
compared with the histological data. To our knowledge,
Fig. 4 Patient with extralobar pulmonary sequestration. PUS at
21 weeks of gestation (a, b), displays a homogenous hyperechoic
lesion (clippers) with an arterial vessel (arrow) entering the mass.
MDCT scans after contrast medium administration (c, d) show a
homogeneously hyperdense mass in the left lower lobe (asterisk). A
feeding artery arising from the aorta (white arrowhead) with a venous
drainage through the azygous system (black arrowheads) can be seen.
MIP reconstructions (e, f) show a marked vascularity of the lesion
(asterisk), and systemic venous drainage (white arrows). On micro-
scopic view (g), effaced pulmonary parenchyma with bronchiolar
dilatation with mucus, alveolar macrophages and haemorrhage (H&E,
94)
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this study is the first to compare prenatal and postnatal
radiological diagnoses with histological findings. Agree-
ment between PUS and histology and MDCT and his-
tology was observed in 76.9 % (20/26) and 94 % (31/33)
of the cases, respectively. Overall, the PPV of the survey
MDCT scans compared with histology was 93.3 %,
compared with a reported value of 70 % in the literature
[19]. As most surgeons consider surgical resection of
these lesions mandatory, MDCT can provide detailed
anatomical localisation of lesions, with the possibility of
3D reconstruction and high spatial resolution. Postpro-
cessing reconstruction can also provide detailed informa-
tion on vascular afferents, and 3D reconstructions in our
study proved to be very helpful to the surgeon during
preoperative planning [24, 25]. Providing a correct diag-
nosis is of utmost importance not only for symptomatic
patients, for whom surgery is mandatory, but also for
asymptomatic ones. In this subset of patients, the nature
of the lesion (e.g. some CPAMs display a potential for
malignant transformation) can prompt a surgical operation
even in the presence of small lesions. The analysis of our
data shows that MDCT should be used as first-step
imaging in the postnatal evaluation of patients with
CCLD, and our work suggests that MDCT can be con-
sidered the best imaging modality in the postnatal eval-
uation of patients with CCLD detected in uterus, with
higher specificity values for CPAM lesions and higher
sensitivity for PS compared to PUS findings. Moreover,
MDCT gives high spatial resolution, enhanced quality and
multiplanar image reformation with detailed information
on vascular afferents. As demonstrated by our results, this
is a very useful tool to define the surgical approach, since
the comparison between MDCT and surgical findings
demonstrates a total agreement in 90.3 % of cases.
Fig. 4 continued
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Furthermore, preoperative MDCT evaluation is highly
predictive of the possibility of a ‘‘not challenging’’ mini-
mally invasive surgery (i.e. thoracoscopic resection) in
patients with small and peripheral intralobar lesions or
extralobar lesions (PS, BC). Thoracoscopic resection in this
subset of lesions allows for more rapid and less painful
healing with a better cosmetic result, and it prevents any
negative effects of the thoracotomy on the patient’s growth.
Since thoracoscopic pulmonary lobe resection is a highly
demanding and potentially dangerous procedure, especially
in infants, it must only be performed by expert thoracic
paediatric surgeons.
In conclusion, postnatal MDCT can provide invaluable
preoperative information on CCLD recognised in uterus.
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